US 8592442
Nilotinib HCl crystalline forms
granted A61PA61P35/00A61P35/02
Quick answer
US patent 8592442 (Nilotinib HCl crystalline forms) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P35/00, A61P35/02, A61P43/00